16+ Peritoneal Mesothelioma Pembrolizumab
Background. Malignant peritoneal mesothelioma is an uncommon primary tumor of the peritoneal lining. We offer treatment and prognosis assistance.
Diagnosis And Management Of Mesothelioma Liou Ame Medical Journal from cdn.amegroups.cn
Peritoneal mesothelioma is a cancer caused by asbestos exposure that develops in the abdomen. Nci supports clinical trials studying new and more effective ways to detect and treat cancer. Mesothelioma treatments include surgery, radiation and chemotherapy.
Peritoneal neoplasia can originate de novo from the peritoneal tissues (primary) or invade or metastasize into the peritoneum from adjacent or remote organs (secondary).
Pembrolizumab as palliative immunotherapy in malignant pleural mesothelioma. Surgery and chemotherapy are the most successful treatments to extend life expectancy. We offer treatment and prognosis assistance. Surgery and chemotherapy are the most successful treatments to improve prognosis.
